402 related articles for article (PubMed ID: 34374098)
1. Multi-parametric MRI (mpMRI) for treatment response assessment of radiation therapy.
Wang C; Padgett KR; Su MY; Mellon EA; Maziero D; Chang Z
Med Phys; 2022 Apr; 49(4):2794-2819. PubMed ID: 34374098
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric magnetic resonance imaging for radiation therapy response monitoring in soft tissue sarcomas: a histology and MRI co-registration algorithm.
Jung M; Bogner B; Diallo TD; Kim S; Arnold P; Füllgraf H; Kurowski K; Bronsert P; Jungmann PM; Kiefer J; Kraus D; Rovedo P; Reisert M; Eisenhardt SU; Bamberg F; Benndorf M; Runkel A
Theranostics; 2023; 13(5):1594-1606. PubMed ID: 37056570
[No Abstract] [Full Text] [Related]
3. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study.
Necchi A; Bandini M; Calareso G; Raggi D; Pederzoli F; Farè E; Colecchia M; Marandino L; Bianchi M; Gallina A; Colombo R; Fossati N; Gandaglia G; Capitanio U; Dehò F; Giannatempo P; Lucianò R; Salonia A; Madison R; Ali SM; Chung JH; Ross JS; Briganti A; Montorsi F; De Cobelli F; Messina A
Eur Urol; 2020 May; 77(5):636-643. PubMed ID: 31882281
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Accuracy of Single-plane Biparametric and Multiparametric Magnetic Resonance Imaging in Prostate Cancer: A Randomized Noninferiority Trial in Biopsy-naïve Men.
Russo F; Mazzetti S; Regge D; Ambrosini I; Giannini V; Manfredi M; De Luca S; Bollito E; Porpiglia F
Eur Urol Oncol; 2021 Dec; 4(6):855-862. PubMed ID: 33893066
[TBL] [Abstract][Full Text] [Related]
5. Multi-parametric MRI for radiotherapy simulation.
Li T; Wang J; Yang Y; Glide-Hurst CK; Wen N; Cai J
Med Phys; 2023 Aug; 50(8):5273-5293. PubMed ID: 36710376
[TBL] [Abstract][Full Text] [Related]
6. Prostate Indeterminate Lesions on Magnetic Resonance Imaging-Biopsy Versus Surveillance: A Literature Review.
Gómez Rivas J; Giganti F; Álvarez-Maestro M; Freire MJ; Kasivisvanathan V; Martinez-Piñeiro L; Emberton M
Eur Urol Focus; 2019 Sep; 5(5):799-806. PubMed ID: 29525382
[TBL] [Abstract][Full Text] [Related]
7. Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.
Amin A; Blazevski A; Thompson J; Scheltema MJ; Hofman MS; Murphy D; Lawrentschuk N; Sathianathen N; Kapoor J; Woo HH; Chalasani V; Rasiah K; van Leeuwen PJ; Tang R; Cusick T; Stricker P; Emmett L
BJU Int; 2020 Apr; 125(4):515-524. PubMed ID: 31957122
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation.
Israël B; Leest MV; Sedelaar M; Padhani AR; Zámecnik P; Barentsz JO
Eur Urol; 2020 Apr; 77(4):469-480. PubMed ID: 31767492
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
[TBL] [Abstract][Full Text] [Related]
11. Prospective analysis of clinically significant prostate cancer detection with [
Bodar YJL; Zwezerijnen BGJC; van der Voorn PJ; Jansen BHE; Smit RS; Kol SQ; Meijer D; de Bie K; Yaqub M; Windhorst BAD; Hendrikse HNH; Vis AN; Oprea-Lager DE
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1731-1742. PubMed ID: 34725727
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy.
Yang F; Ford JC; Dogan N; Padgett KR; Breto AL; Abramowitz MC; Dal Pra A; Pollack A; Stoyanova R
Transl Androl Urol; 2018 Jun; 7(3):445-458. PubMed ID: 30050803
[TBL] [Abstract][Full Text] [Related]
13. PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer.
Tran V; Hong A; Sutherland T; Taubman K; Lee SF; Lenaghan D; Sethi K; Corcoran NM; Lawrentschuk N; Woo H; Tarlinton L; Bolton D; Spelman T; Thomas L; Booth R; Hegarty J; Perry E; Wong LM
BMJ Open; 2022 Sep; 12(9):e061815. PubMed ID: 36123093
[TBL] [Abstract][Full Text] [Related]
14. Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.
Stabile A; Giganti F; Kasivisvanathan V; Giannarini G; Moore CM; Padhani AR; Panebianco V; Rosenkrantz AB; Salomon G; Turkbey B; Villeirs G; Barentsz JO
Eur Urol Oncol; 2020 Apr; 3(2):145-167. PubMed ID: 32192942
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
[TBL] [Abstract][Full Text] [Related]
16. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
Jambor I; Falagario U; Ratnani P; Perez IM; Demir K; Merisaari H; Sobotka S; Haines GK; Martini A; Beksac AT; Lewis S; Pahikkala T; Wiklund P; Nair S; Tewari A
J Magn Reson Imaging; 2020 Apr; 51(4):1075-1085. PubMed ID: 31566845
[TBL] [Abstract][Full Text] [Related]
17. Impact of 3T multiparametric MRI and FDG-PET-CT in the evaluation of occult primary cancer with cervical node metastasis.
Gődény M; Lengyel Z; Polony G; Nagy ZT; Léránt G; Zámbó O; Remenár É; Tamás L; Kásler M
Cancer Imaging; 2016 Nov; 16(1):38. PubMed ID: 27814768
[TBL] [Abstract][Full Text] [Related]
18. Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework.
Reynolds HM; Williams S; Jackson P; Mitchell C; Hofman MS; Hicks RJ; Murphy DG; Haworth A
BJU Int; 2019 Jun; 123(6):1020-1030. PubMed ID: 30536698
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition.
Sachpazidis I; Mavroidis P; Zamboglou C; Klein CM; Grosu AL; Baltas D
Radiat Oncol; 2020 Oct; 15(1):242. PubMed ID: 33081804
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]